Geron Net Receivables vs Total Revenue Analysis

GERN Stock

USD 4.07 0.05 1.24%

Geron financial indicator trend analysis is much more than just examining Geron latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Geron is a good investment. Please check the relationship between Geron Net Receivables and its Total Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.

Net Receivables vs Total Revenue

Net Receivables vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Geron Net Receivables account and Total Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Geron's Net Receivables and Total Revenue is -0.04. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Geron, assuming nothing else is changed. The correlation between historical values of Geron's Net Receivables and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Geron are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Net Receivables i.e., Geron's Net Receivables and Total Revenue go up and down completely randomly.

Correlation Coefficient

-0.04

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Net Receivables

Total Revenue

Total revenue comprises all receipts Geron generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Geron's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Geron current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.At this time, Geron's Selling General Administrative is very stable compared to the past year. As of the 25th of November 2024, Issuance Of Capital Stock is likely to grow to about 224 M, though Enterprise Value Over EBITDA is likely to grow to (6.62).

Geron fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Net Receivables	Common Stock	Other Assets	Long Term Debt	Common Stock Total Equity
Total Assets		0.87	0.84	0.87	0.73	0.61	0.66	-0.82	0.62	0.63	0.83	0.57	0.99	0.94	0.74	-0.02	0.89	0.87	0.73	0.99	0.83	0.36	0.52	0.8	0.48	0.91
Short Long Term Debt Total	0.87		0.95	0.94	0.38	0.79	0.77	-0.76	0.8	0.77	0.61	0.71	0.88	0.96	0.91	0.21	0.79	0.98	0.76	0.89	0.89	0.59	0.31	0.98	0.67	0.94
Other Current Liab	0.84	0.95		0.92	0.38	0.71	0.77	-0.8	0.81	0.71	0.57	0.79	0.85	0.94	0.87	0.13	0.82	0.95	0.73	0.86	0.84	0.62	0.39	0.96	0.66	0.94
Total Current Liabilities	0.87	0.94	0.92		0.39	0.67	0.57	-0.77	0.74	0.85	0.54	0.67	0.9	0.95	0.78	0.18	0.8	0.97	0.65	0.91	0.94	0.58	0.36	0.92	0.55	0.92
Total Stockholder Equity	0.73	0.38	0.38	0.39		0.17	0.39	-0.61	0.24	0.29	0.79	0.26	0.69	0.52	0.34	-0.24	0.64	0.39	0.43	0.68	0.36	0.07	0.56	0.3	0.12	0.53
Property Plant And Equipment Net	0.61	0.79	0.71	0.67	0.17		0.69	-0.33	0.52	0.53	0.46	0.38	0.6	0.66	0.78	0.44	0.38	0.75	0.82	0.61	0.65	0.35	-0.09	0.79	0.76	0.59
Net Debt	0.66	0.77	0.77	0.57	0.39	0.69		-0.54	0.71	0.27	0.68	0.71	0.62	0.7	0.86	0.22	0.56	0.7	0.86	0.63	0.51	0.34	0.15	0.75	0.76	0.74
Retained Earnings	-0.82	-0.76	-0.8	-0.77	-0.61	-0.33	-0.54		-0.65	-0.65	-0.56	-0.62	-0.86	-0.88	-0.69	0.41	-0.99	-0.78	-0.43	-0.84	-0.66	-0.46	-0.83	-0.73	-0.25	-0.91
Accounts Payable	0.62	0.8	0.81	0.74	0.24	0.52	0.71	-0.65		0.63	0.48	0.91	0.62	0.73	0.86	0.13	0.63	0.82	0.61	0.63	0.57	0.75	0.32	0.84	0.58	0.82
Cash	0.63	0.77	0.71	0.85	0.29	0.53	0.27	-0.65	0.63		0.26	0.52	0.67	0.75	0.63	0.16	0.62	0.82	0.35	0.68	0.78	0.7	0.31	0.78	0.36	0.72
Non Current Assets Total	0.83	0.61	0.57	0.54	0.79	0.46	0.68	-0.56	0.48	0.26		0.49	0.75	0.65	0.62	-0.03	0.64	0.6	0.77	0.75	0.47	0.13	0.38	0.51	0.38	0.67
Non Currrent Assets Other	0.57	0.71	0.79	0.67	0.26	0.38	0.71	-0.62	0.91	0.52	0.49		0.55	0.66	0.79	0.16	0.59	0.75	0.6	0.56	0.49	0.71	0.26	0.76	0.64	0.78
Cash And Short Term Investments	0.99	0.88	0.85	0.9	0.69	0.6	0.62	-0.86	0.62	0.67	0.75	0.55		0.95	0.73	-0.05	0.92	0.89	0.67	1.0	0.86	0.39	0.56	0.82	0.45	0.92
Common Stock Shares Outstanding	0.94	0.96	0.94	0.95	0.52	0.66	0.7	-0.88	0.73	0.75	0.65	0.66	0.95		0.82	0.02	0.91	0.95	0.68	0.96	0.91	0.52	0.51	0.92	0.53	0.98
Non Current Liabilities Total	0.74	0.91	0.87	0.78	0.34	0.78	0.86	-0.69	0.86	0.63	0.62	0.79	0.73	0.82		0.13	0.69	0.9	0.81	0.74	0.63	0.6	0.29	0.91	0.76	0.87
Other Current Assets	-0.02	0.21	0.13	0.18	-0.24	0.44	0.22	0.41	0.13	0.16	-0.03	0.16	-0.05	0.02	0.13		-0.37	0.17	0.32	-0.01	0.28	0.21	-0.82	0.24	0.57	-0.04
Other Stockholder Equity	0.89	0.79	0.82	0.8	0.64	0.38	0.56	-0.99	0.63	0.62	0.64	0.59	0.92	0.91	0.69	-0.37		0.81	0.49	0.9	0.72	0.41	0.8	0.74	0.28	0.93
Total Liab	0.87	0.98	0.95	0.97	0.39	0.75	0.7	-0.78	0.82	0.82	0.6	0.75	0.89	0.95	0.9	0.17	0.81		0.74	0.9	0.88	0.62	0.35	0.97	0.65	0.95
Property Plant And Equipment Gross	0.73	0.76	0.73	0.65	0.43	0.82	0.86	-0.43	0.61	0.35	0.77	0.6	0.67	0.68	0.81	0.32	0.49	0.74		0.68	0.56	0.19	0.03	0.71	0.77	0.67
Total Current Assets	0.99	0.89	0.86	0.91	0.68	0.61	0.63	-0.84	0.63	0.68	0.75	0.56	1.0	0.96	0.74	-0.01	0.9	0.9	0.68		0.88	0.4	0.53	0.83	0.47	0.93
Short Term Debt	0.83	0.89	0.84	0.94	0.36	0.65	0.51	-0.66	0.57	0.78	0.47	0.49	0.86	0.91	0.63	0.28	0.72	0.88	0.56	0.88		0.45	0.26	0.85	0.46	0.82
Net Receivables	0.36	0.59	0.62	0.58	0.07	0.35	0.34	-0.46	0.75	0.7	0.13	0.71	0.39	0.52	0.6	0.21	0.41	0.62	0.19	0.4	0.45		0.18	0.71	0.48	0.58
Common Stock	0.52	0.31	0.39	0.36	0.56	-0.09	0.15	-0.83	0.32	0.31	0.38	0.26	0.56	0.51	0.29	-0.82	0.8	0.35	0.03	0.53	0.26	0.18		0.28	-0.25	0.55
Other Assets	0.8	0.98	0.96	0.92	0.3	0.79	0.75	-0.73	0.84	0.78	0.51	0.76	0.82	0.92	0.91	0.24	0.74	0.97	0.71	0.83	0.85	0.71	0.28		0.72	0.91
Long Term Debt	0.48	0.67	0.66	0.55	0.12	0.76	0.76	-0.25	0.58	0.36	0.38	0.64	0.45	0.53	0.76	0.57	0.28	0.65	0.77	0.47	0.46	0.48	-0.25	0.72		0.55
Common Stock Total Equity	0.91	0.94	0.94	0.92	0.53	0.59	0.74	-0.91	0.82	0.72	0.67	0.78	0.92	0.98	0.87	-0.04	0.93	0.95	0.67	0.93	0.82	0.58	0.55	0.91	0.55

Click cells to compare fundamentals

Geron Account Relationship Matchups

Geron fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	165.5M	270.7M	226.0M	190.6M	394.1M	413.8M
Other Current Liab	26.6M	22.3M	37.0M	44.6M	54.1M	56.8M
Total Current Liabilities	28.2M	30.9M	45.5M	76.7M	108.1M	113.5M
Total Stockholder Equity	135.2M	210.9M	126.4M	80.0M	247.9M	132.0M
Property Plant And Equipment Net	408K	658K	5.4M	793K	4.7M	5.0M
Net Debt	(11.4M)	19.4M	20.1M	(1.5M)	14.8M	15.5M
Retained Earnings	(1.1B)	(1.2B)	(1.3B)	(1.4B)	(1.6B)	(1.5B)
Accounts Payable	1.2M	6.9M	6.7M	10.2M	6.2M	6.5M
Cash	13.9M	10.3M	34.9M	57.2M	71.1M	40.5M
Non Current Assets Total	23.9M	70.9M	38.8M	10.3M	52.7M	55.4M
Non Currrent Assets Other	3.9M	6.8M	4.8M	9.5M	4.7M	4.5M
Cash And Short Term Investments	139.6M	196.6M	183.7M	173.1M	333.7M	350.4M
Common Stock Shares Outstanding	190.2M	271.5M	327.6M	380.8M	570.6M	599.2M
Liabilities And Stockholders Equity	165.5M	270.7M	226.0M	190.6M	394.1M	413.8M
Non Current Liabilities Total	2.2M	28.8M	54.1M	33.9M	38.1M	40.0M
Other Current Assets	2.0M	2.9M	1.7M	4.4M	6.0M	4.0M
Other Stockholder Equity	1.2B	1.4B	1.4B	1.5B	1.8B	1.9B
Total Liab	30.4M	59.8M	99.6M	110.6M	146.1M	153.4M
Property Plant And Equipment Gross	2.9M	6.0M	6.0M	793K	6.0M	6.3M
Total Current Assets	141.6M	199.9M	187.2M	180.2M	341.3M	358.4M
Accumulated Other Comprehensive Income	132K	78K	(173K)	(219K)	185K	194.3K
Net Receivables	802K	722K	1.8M	3.1M	1.7M	1.3M
Common Stock	200K	310K	324K	390K	545K	572.3K
Other Assets	964K	1.5M	4.8M	5.4M	6.2M	6.5M
Common Stock Total Equity	200K	310K	324K	390K	448.5K	470.9K
Short Term Investments	125.7M	186.4M	148.9M	115.9M	263.7M	276.9M
Property Plant Equipment	408K	658K	650K	793K	713.7K	1.4M
Inventory	(802K)	(722K)	(1.4M)	(3.1M)	(2.8M)	(2.7M)
Net Tangible Assets	137.4M	210.9M	126.4M	80.0M	92.0M	139.7M
Retained Earnings Total Equity	(1.1B)	(1.2B)	(1.3B)	(1.4B)	(1.3B)	(1.3B)
Capital Surpluse	1.2B	1.4B	1.4B	1.5B	1.7B	1.3B
Long Term Investments	19.7M	63.4M	28.7M	0.0	43.3M	28.5M
Net Invested Capital	135.2M	235.0M	176.2M	131.2M	329.9M	202.6M
Net Working Capital	113.4M	168.9M	141.7M	103.6M	233.3M	158.5M
Capital Stock	200K	310K	324K	390K	545K	358.4K

When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock:

How To Invest In Geron

Details

Is Geron Stock a good investment?

Details

What is Geron's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.

You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.32)

Revenue Per Share

0.047

Quarterly Revenue Growth

171.384

Return On Assets

(0.30)

Return On Equity

(0.69)

The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Geron Net Receivables vs Total Revenue Analysis

Net Receivables vs Total Revenue

Net Receivables vs Total Revenue Correlation Analysis

Correlation Coefficient

Net Receivables

Total Revenue

Geron fundamental ratios Correlations

Geron Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Geron fundamental ratios Accounts

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Total Liab	+ 0.98	Short Long Term Debt Total
Other Assets	+ 0.98	Short Long Term Debt Total
Common Stock Total Equity	+ 0.98	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.99	Retained Earnings
Common Stock Total Equity	- 0.91	Retained Earnings
Common Stock Shares Outstanding	- 0.88	Retained Earnings
Cash And Short Term Investments	- 0.86	Retained Earnings
Total Current Assets	- 0.84	Retained Earnings
Common Stock	- 0.83	Retained Earnings